CLINICAL_TRIALS
trial_result
· 2014-06-20
Clinical Trial Update: A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI® [Phase 3]
Summary
Phase 3 trial update comparing Tobrineb, Actitob, and Bramitob with TOBI in cystic fibrosis; results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2014-06-20